Sarcoidosis Secondary to Lymphocyte Active Immunotherapy Treated With Infliximab

Anais Brasileiros de Dermatologia - Brazil
doi 10.1590/abd1806-4841.20187624
Full Text
Abstract

Available in full text

Categories
Dermatology
Date
Authors
Publisher

FapUNIFESP (SciELO)

Related search

Steroid Refractory Autoimmune Haemolytic Anaemia Secondary to Sarcoidosis Successfully Treated With Rituximab and Mycophenolate Mofetil

Case Reports in Hematology
2016English

Lymphocyte Sensitization in Sarcoidosis.

BMJ
1971English

P106: Change of RSA Patients' Subsequent Pregnancy After Lymphocyte Active Immunotherapy

American Journal of Reproductive Immunology
GynecologyReproductive MedicineImmunologyObstetricsAllergy
2018English

P2.01-34 Prognostic Value of Neutrophil to Lymphocyte Ratio for Metastatic NSCLC Patients Treated With Immunotherapy and Ramucirumab Plus Docetaxel.

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Polyarthritis Flare in Patient With Ankylosing Spondylitis Treated With Infliximab

Reumatismo
Rheumatology
2011English

Long-Term Outcomes of Refractory Neurosarcoidosis Treated With Infliximab

Journal of Neurology
Neurology
2017English

Letter: Is There a Role for Infliximab Biosimilar in Patients With Inflammatory Bowel Disease With Secondary Loss of Response to Infliximab Innovator?

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Nivolumab-Induced Colitis Treated by Infliximab

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2017English

Enhanced Alveolar Lymphocyte Proliferation in Sarcoidosis Patients

Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
1988English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy